BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 25330835)

  • 1. How do we treat life-threatening anemia in a Jehovah's Witness patient?
    Posluszny JA; Napolitano LM
    Transfusion; 2014 Dec; 54(12):3026-34. PubMed ID: 25330835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of hemoglobin raffimer for postoperative life-threatening anemia in a Jehovah's Witness.
    Lanzinger MJ; Niklason LE; Shannon M; Hill SE
    Can J Anaesth; 2005 Apr; 52(4):369-73. PubMed ID: 15814750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of acute anemia in a Jehovah's Witness patient with acute lymphoblastic leukemia with polymerized bovine hemoglobin-based oxygen carrier: a case report and review of literature.
    Donahue LL; Shapira I; Shander A; Kolitz J; Allen S; Greenburg G
    Transfusion; 2010 Jul; 50(7):1561-7. PubMed ID: 20456679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine hemoglobin: a nontraditional approach to the management of acute anemia in a Jehovah's Witness patient with autoimmune hemolytic anemia.
    Jordan SD; Alexander E
    J Pharm Pract; 2013 Jun; 26(3):257-60. PubMed ID: 22869910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of anaemia in the polytrauma Jehovah's Witness.
    Murphy DP; O'Donnell T; McDonnell J; McElwain JP
    Ir Med J; 2003 Jan; 96(1):8-10. PubMed ID: 12617434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When blood is not an option: factors affecting survival after the use of a hemoglobin-based oxygen carrier in 54 patients with life-threatening anemia.
    Mackenzie CF; Moon-Massat PF; Shander A; Javidroozi M; Greenburg AG
    Anesth Analg; 2010 Mar; 110(3):685-93. PubMed ID: 20042443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large volume polymerized haemoglobin solution in a Jehovah's Witness following abruptio placentae.
    Cothren CC; Moore EE; Long JS; Haenel JB; Johnson JL; Ciesla DJ
    Transfus Med; 2004 Jun; 14(3):241-6. PubMed ID: 15180817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy in Acutely Anemic Jehovah's Witnesses: An Evidence-Based Review.
    McConachie SM; Almadrahi Z; Wahby KA; Wilhelm SM
    Ann Pharmacother; 2018 Sep; 52(9):910-919. PubMed ID: 29592539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses.
    Ball AM; Winstead PS
    Pharmacotherapy; 2008 Nov; 28(11):1383-90. PubMed ID: 18956998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total Knee Arthroplasty Is Safe in Jehovah's Witness Patients-A 12-Year Perspective.
    Wolfson TS; Novikov D; Chen KK; Kim KY; Anoushiravani AA; Deshmukh AJ; Lajam CM
    J Knee Surg; 2020 Jan; 33(1):34-41. PubMed ID: 30620987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative Anemia and Single Red Blood Cell Transfusion During Cardiac Surgery: An Assessment of Postoperative Outcome Including Patients Refusing Blood Transfusion.
    Hogervorst EK; Rosseel PM; van de Watering LM; Brand A; Bentala M; van der Bom JG; van der Meer NJ
    J Cardiothorac Vasc Anesth; 2016 Apr; 30(2):363-72. PubMed ID: 26809765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient.
    Chojnowski K; Janus A; Bliźniewska K; Robak M; Treliński J
    Transfusion; 2016 Oct; 56(10):2438-2442. PubMed ID: 27385671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine Hemoglobin-Based Oxygen Carrier Treatment in a Severely Anemic Jehovah's Witness Patient After Cystoprostatectomy and Nephrectomy: A Case Report.
    Brotman I; Kocher M; McHugh S
    A A Pract; 2019 Apr; 12(7):243-245. PubMed ID: 30272592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of life-threatening epistaxis in a Jehovah's Witness.
    Stark RD; Coatesworth AP; Tucker AG
    Int J Clin Pract; 2003; 57(1):60-1. PubMed ID: 12587946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contemporary approach to the care of Jehovah's witnesses.
    Hughes DB; Ullery BW; Barie PS
    J Trauma; 2008 Jul; 65(1):237-47. PubMed ID: 18580506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful use of a polymerized hemoglobin blood substitute in a critically anemic Jehovah's Witness.
    Allison G; Feeney C
    South Med J; 2004 Dec; 97(12):1257-8. PubMed ID: 15646766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jehovah's Witnesses and cardiac surgery: a single institution's experience.
    McCartney S; Guinn N; Roberson R; Broomer B; White W; Hill S
    Transfusion; 2014 Oct; 54(10 Pt 2):2745-52. PubMed ID: 24809815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of pregnancy in a Jehovah's Witness.
    Gyamfi C; Berkowitz RL
    Obstet Gynecol Clin North Am; 2007 Sep; 34(3):357-65, ix. PubMed ID: 17921004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difficult to swallow: warm autoimmune hemolytic anemia in a Jehovah's Witness treated with hemoglobin concentrate complicated by achalasia.
    Epperla N; Strouse C; VanSandt AM; Foy P
    Transfusion; 2016 Jul; 56(7):1801-6. PubMed ID: 27062564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Experiences With PEGylated Carboxyhemoglobin Bovine in Anemic Jehovah's Witnesses: A Case Series and Review of the Literature.
    McConachie S; Wahby K; Almadrahi Z; Wilhelm S
    J Pharm Pract; 2020 Jun; 33(3):372-377. PubMed ID: 30518297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.